NASDAQ: ABVC
Abvc Biopharma Inc Stock Ownership - Who owns Abvc Biopharma?

Insider buying vs selling

Have Abvc Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ABVC insiders and whales buy or sell their stock.

ABVC Shareholders

What type of owners hold Abvc Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tsung Shann Jiang72.16%12,103,971$34.86MInsider
Shuling Jiang47.15%7,908,805$22.78MInsider
Eugene Jiang4.37%732,716$2.11MInsider
Yoshinobu Odaira0.98%163,702$471.46kInsider
Geode Capital Management LLC0.62%104,482$300.91kInstitution
Shinyu Miao0.40%67,378$194.05kInsider
Xtx Topco Ltd0.36%60,439$174.06kInstitution
Vanguard Group Inc0.28%46,947$135.21kInstitution
Ubs Group Ag0.17%29,003$83.53kInstitution
Northern Trust Corp0.11%19,135$55.11kInstitution

1 of 3

ABVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC1.35%98.65%
ACRV60.12%39.88%Net SellingNet Selling
LVTX30.58%38.47%
GRCE29.10%50.93%
PLUR0.05%99.95%Net Buying

Abvc Biopharma Stock Ownership FAQ

Who owns Abvc Biopharma?

Abvc Biopharma (NASDAQ: ABVC) is owned by 1.71% institutional shareholders, 125.36% Abvc Biopharma insiders, and 0.00% retail investors. Tsung Shann Jiang is the largest individual Abvc Biopharma shareholder, owning 12.10M shares representing 72.16% of the company. Tsung Shann Jiang's Abvc Biopharma shares are currently valued at $29.05M.

If you're new to stock investing, here's how to buy Abvc Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.